Pharmacokinetic study on biapenem

CHEMOTHERAPY

Volumn 42, Issue , 1994, Pages 277-284

  Saito, Akira ^a   Miura, Toshiaki ^a   Tarao, Fumiaki ^a   Sato, Kiyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Biapenem; Cross over; IPM CS

Indexed keywords

BIAPENEM; CARBAPENEM DERIVATIVE; CILASTATIN PLUS IMIPENEM; DRUG METABOLITE; LJC 10905; LJC 10906; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PHARMACOKINETICS; URINARY EXCRETION; VOLUNTEER;

EID: 0028555806     PISSN: 00093165     EISSN: None     Source Type: Journal    
DOI: 10.11250/chemotherapy1953.42.Supplement4_277     Document Type: Article

References (6)

1. Petersen P J, Jacobus N V, Weiss W J and Testa R T: In vitro and in vivo activities of LJC 10,627, a new carbapenem with stability to dehydropeptidase I Antimicrob. Agents Chemother 35: 203-207, 1991.
2. Hikida M, Kawashima K, Nishiki K, Furukawa Y, Kazuaki K, Nishizawa N, and Kuwano S: Renal dehydropeptidase 1 stability of LJC 10,627, a new carbapenem antibiotic. Antimicrob Agents and Chemother 36: 481~483, 1992.
3. Ubukata K, Hikida M, Yoshida M, Nishiki K, Furukawa Y, Tashiro K, Konno M, and Mitsuhashi S: In vitro activity of LJC 10627, a new carbapenem antibiotic with high stability to dehydropeptidase I Antimicrob. Agents and Chemother 34: 994~1000, 1990.
4. Chemotherapy 33 (S-4): 379~391, 1985.
5. Chemotherapy 39 (S-3): 227~235, 1991.
6. Chemodherapy 40 (S-1): 276~282, 1992.